US2004265819A1PendingUtilityA1
Kidney-specific urate transporter and gene thereof
Priority: Sep 21, 2001Filed: Aug 22, 2002Published: Dec 30, 2004
Est. expirySep 21, 2021(expired)· nominal 20-yr term from priority
A61P 19/06C07K 14/47
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It is intended to identify and provide a novel urate transporter gene participating in the urate transport in the kidney and a urate transporter which is a polypeptide encoded by the above gene. Namely, a protein comprising the amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom by deletion, substitution or addition of one to several amino acids and being capable of transporting uric acid and its analogs; and a gene encoding this protein.
Claims
exact text as granted — not AI-modified1 . A protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom by deletion, substitution or addition of one to several amino acids and being capable of transporting uric acid and its analogs.
2 . The protein according to claim 1 which is derived from human.
3 . The protein according to claim 1 which is derived from organs, tissues or cultured cells.
4 . A gene encoding the protein according to claim 1 .
5 . DNA comprising the base sequence represented by SEQ ID NO:1 or DNA hybridizing with the DNA under a stringent condition and encoding a protein being capable of transporting uric acid and its analogs or exchanging uric acid and the other anion.
6 . The gene according to claim 5 , which is derived from human.
7 . The gene according to claim 5 , which is derived from organs, tissues or cultured cells.
8 . The gene according to claim 4 or a plasmid comprising a gene encoding a protein of the gene.
9 . The plasmid according to claim 8 , wherein the plasmid is an expression plasmid.
10 . Host cells transformed with the plasmid according to claim 8 .
11 . Nucleotides comprising a partial sequence of consecutive 14 bases or more in the base sequence represented by SEQ ID NO:1 or a complementary sequence thereof.
12 . The nucleotides according to claim 11 , used as a probe to detect the gene encoding the protein being capable of transporting uric acid and its analogs or exchanging uric acid and other anion.
13 . The nucleotides according to claim 11 , used to modulate the expression of the gene encoding the protein being capable of transporting uric acid and its analogs or exchanging uric acid and other anion.
14 . An antibody against the protein according to claim 1 .
15 . A method for detecting an action of a subject substance as a substrate for an ability to transport uric acid of the protein and its analogs or exchange uric acid and other anion using the protein according to claim 1 .
16 . A method for screening substances having a uricosuric regulating action using the protein according to claim 1 .
17 . A uricosuric regulating agent capable of being screened by the method according to claim 16 .
18 . A method for changing kinetics of uric acid and its analogs transported by the protein in the kidney, by modulating an ability to transport uric acid of the protein and its analogs or exchange the uric acid and other anion, using the protein according to claim 1 , a specific antibody thereof, a function accelerating substance thereof or a function inhibiting substance thereof.
19 . A method for changing effects of uric acid and its analogs transported by the protein on kinetics in the kidney, by modulating an ability to transport uric acid of the protein and its analogs or exchange the uric acid and other anion, using the protein according to claim 1 , a specific antibody thereof, a function accelerating substance thereof or a function inhibiting substance thereof.
20 . A method for changing effects of uric acid and its analogs transported by the protein on total blood concentrations, by modulating an ability to transport uric acid of the protein and its analogs or exchange the uric acid and other anions, using the protein according to claim 1 , a specific antibody thereof, a function accelerating substance thereof or a function inhibiting substance thereof.
21 . A method for detecting and changing effects of uric acid and its analogs transported by the protein on kinetics in the kidney, by excessively expressing the protein in the certain cells or by modulating an ability to transport uric acid of the protein existing in the cells and its analogs, using the protein according to claim 1 , a specific antibody thereof, a function accelerating substance thereof or a function inhibiting substance thereof, and cDNA (complementary DNA) encoding the same.Join the waitlist — get patent alerts
Track US2004265819A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.